Global Minimal Residual Disease Mrd Testing Market Research Report 2026(Status and Outlook)

December 2025 | 151 pages | ID: MCAF9EF05964EN
Bosson Research

Abstracts

The global Minimal Residual Disease Mrd Testing market size was estimated at USD 655.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Minimal Residual Disease Mrd Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Minimal Residual Disease Mrd Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Minimal Residual Disease Mrd Testing market.

Global Minimal Residual Disease Mrd Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company
Sysmex Corporation
Natera
Asuragen
Quest Diagnostics
Mission Bio
LabCorp
Guardant Health
NeoGenomics Laboratories
ARUP Laboratories
NeoGenomics , Inc
Opko Health
Bio-Rad Laboratories

Market Segmentation (by Type)

Flow Cytometry
Polymerase Chain Reaction
Next-generation Sequencing
Liquid Biopsies

Market Segmentation (by Application)

Specialty Clinics
Hospitals
Research Institutions

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Minimal Residual Disease Mrd Testing Market

Overview of the regional outlook of the Minimal Residual Disease Mrd Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Minimal Residual Disease Mrd Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Minimal Residual Disease Mrd Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Minimal Residual Disease Mrd Testing
1.2 Key Market Segments
  1.2.1 Minimal Residual Disease Mrd Testing Segment by Type
  1.2.2 Minimal Residual Disease Mrd Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Minimal Residual Disease Mrd Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Minimal Residual Disease Mrd Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Minimal Residual Disease Mrd Testing Product Life Cycle
3.3 Global Minimal Residual Disease Mrd Testing Sales by Manufacturers (2020-2025)
3.4 Global Minimal Residual Disease Mrd Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Minimal Residual Disease Mrd Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Minimal Residual Disease Mrd Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Minimal Residual Disease Mrd Testing Market Competitive Situation and Trends
  3.8.1 Minimal Residual Disease Mrd Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Minimal Residual Disease Mrd Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MINIMAL RESIDUAL DISEASE MRD TESTING INDUSTRY CHAIN ANALYSIS

4.1 Minimal Residual Disease Mrd Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MINIMAL RESIDUAL DISEASE MRD TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Minimal Residual Disease Mrd Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Minimal Residual Disease Mrd Testing Market
5.7 ESG Ratings of Leading Companies

6 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Minimal Residual Disease Mrd Testing Sales Market Share by Type (2020-2025)
6.3 Global Minimal Residual Disease Mrd Testing Market Size by Type (2020-2025)
6.4 Global Minimal Residual Disease Mrd Testing Price by Type (2020-2025)

7 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Minimal Residual Disease Mrd Testing Market Sales by Application (2020-2025)
7.3 Global Minimal Residual Disease Mrd Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Minimal Residual Disease Mrd Testing Sales Growth Rate by Application (2020-2025)

8 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET SALES BY REGION

8.1 Global Minimal Residual Disease Mrd Testing Sales by Region
  8.1.1 Global Minimal Residual Disease Mrd Testing Sales by Region
  8.1.2 Global Minimal Residual Disease Mrd Testing Sales Market Share by Region
8.2 Global Minimal Residual Disease Mrd Testing Market Size by Region
  8.2.1 Global Minimal Residual Disease Mrd Testing Market Size by Region
  8.2.2 Global Minimal Residual Disease Mrd Testing Market Size by Region
8.3 North America
  8.3.1 North America Minimal Residual Disease Mrd Testing Sales by Country
  8.3.2 North America Minimal Residual Disease Mrd Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Minimal Residual Disease Mrd Testing Sales by Country
  8.4.2 Europe Minimal Residual Disease Mrd Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Minimal Residual Disease Mrd Testing Sales by Region
  8.5.2 Asia Pacific Minimal Residual Disease Mrd Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Minimal Residual Disease Mrd Testing Sales by Country
  8.6.2 South America Minimal Residual Disease Mrd Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Minimal Residual Disease Mrd Testing Sales by Region
  8.7.2 Middle East and Africa Minimal Residual Disease Mrd Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Minimal Residual Disease Mrd Testing by Region(2020-2025)
9.2 Global Minimal Residual Disease Mrd Testing Revenue Market Share by Region (2020-2025)
9.3 Global Minimal Residual Disease Mrd Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Minimal Residual Disease Mrd Testing Production
  9.4.1 North America Minimal Residual Disease Mrd Testing Production Growth Rate (2020-2025)
  9.4.2 North America Minimal Residual Disease Mrd Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Minimal Residual Disease Mrd Testing Production
  9.5.1 Europe Minimal Residual Disease Mrd Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Minimal Residual Disease Mrd Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Minimal Residual Disease Mrd Testing Production (2020-2025)
  9.6.1 Japan Minimal Residual Disease Mrd Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Minimal Residual Disease Mrd Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Minimal Residual Disease Mrd Testing Production (2020-2025)
  9.7.1 China Minimal Residual Disease Mrd Testing Production Growth Rate (2020-2025)
  9.7.2 China Minimal Residual Disease Mrd Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Sysmex Corporation
  10.1.1 Sysmex Corporation Basic Information
  10.1.2 Sysmex Corporation Minimal Residual Disease Mrd Testing Product Overview
  10.1.3 Sysmex Corporation Minimal Residual Disease Mrd Testing Product Market Performance
  10.1.4 Sysmex Corporation Business Overview
  10.1.5 Sysmex Corporation SWOT Analysis
  10.1.6 Sysmex Corporation Recent Developments
10.2 Natera
  10.2.1 Natera Basic Information
  10.2.2 Natera Minimal Residual Disease Mrd Testing Product Overview
  10.2.3 Natera Minimal Residual Disease Mrd Testing Product Market Performance
  10.2.4 Natera Business Overview
  10.2.5 Natera SWOT Analysis
  10.2.6 Natera Recent Developments
10.3 Asuragen
  10.3.1 Asuragen Basic Information
  10.3.2 Asuragen Minimal Residual Disease Mrd Testing Product Overview
  10.3.3 Asuragen Minimal Residual Disease Mrd Testing Product Market Performance
  10.3.4 Asuragen Business Overview
  10.3.5 Asuragen SWOT Analysis
  10.3.6 Asuragen Recent Developments
10.4 Quest Diagnostics
  10.4.1 Quest Diagnostics Basic Information
  10.4.2 Quest Diagnostics Minimal Residual Disease Mrd Testing Product Overview
  10.4.3 Quest Diagnostics Minimal Residual Disease Mrd Testing Product Market Performance
  10.4.4 Quest Diagnostics Business Overview
  10.4.5 Quest Diagnostics Recent Developments
10.5 Mission Bio
  10.5.1 Mission Bio Basic Information
  10.5.2 Mission Bio Minimal Residual Disease Mrd Testing Product Overview
  10.5.3 Mission Bio Minimal Residual Disease Mrd Testing Product Market Performance
  10.5.4 Mission Bio Business Overview
  10.5.5 Mission Bio Recent Developments
10.6 LabCorp
  10.6.1 LabCorp Basic Information
  10.6.2 LabCorp Minimal Residual Disease Mrd Testing Product Overview
  10.6.3 LabCorp Minimal Residual Disease Mrd Testing Product Market Performance
  10.6.4 LabCorp Business Overview
  10.6.5 LabCorp Recent Developments
10.7 Guardant Health
  10.7.1 Guardant Health Basic Information
  10.7.2 Guardant Health Minimal Residual Disease Mrd Testing Product Overview
  10.7.3 Guardant Health Minimal Residual Disease Mrd Testing Product Market Performance
  10.7.4 Guardant Health Business Overview
  10.7.5 Guardant Health Recent Developments
10.8 NeoGenomics Laboratories
  10.8.1 NeoGenomics Laboratories Basic Information
  10.8.2 NeoGenomics Laboratories Minimal Residual Disease Mrd Testing Product Overview
  10.8.3 NeoGenomics Laboratories Minimal Residual Disease Mrd Testing Product Market Performance
  10.8.4 NeoGenomics Laboratories Business Overview
  10.8.5 NeoGenomics Laboratories Recent Developments
10.9 ARUP Laboratories
  10.9.1 ARUP Laboratories Basic Information
  10.9.2 ARUP Laboratories Minimal Residual Disease Mrd Testing Product Overview
  10.9.3 ARUP Laboratories Minimal Residual Disease Mrd Testing Product Market Performance
  10.9.4 ARUP Laboratories Business Overview
  10.9.5 ARUP Laboratories Recent Developments
10.10 NeoGenomics , Inc
  10.10.1 NeoGenomics , Inc Basic Information
  10.10.2 NeoGenomics , Inc Minimal Residual Disease Mrd Testing Product Overview
  10.10.3 NeoGenomics , Inc Minimal Residual Disease Mrd Testing Product Market Performance
  10.10.4 NeoGenomics , Inc Business Overview
  10.10.5 NeoGenomics , Inc Recent Developments
10.11 Opko Health
  10.11.1 Opko Health Basic Information
  10.11.2 Opko Health Minimal Residual Disease Mrd Testing Product Overview
  10.11.3 Opko Health Minimal Residual Disease Mrd Testing Product Market Performance
  10.11.4 Opko Health Business Overview
  10.11.5 Opko Health Recent Developments
10.12 Bio-Rad Laboratories
  10.12.1 Bio-Rad Laboratories Basic Information
  10.12.2 Bio-Rad Laboratories Minimal Residual Disease Mrd Testing Product Overview
  10.12.3 Bio-Rad Laboratories Minimal Residual Disease Mrd Testing Product Market Performance
  10.12.4 Bio-Rad Laboratories Business Overview
  10.12.5 Bio-Rad Laboratories Recent Developments

11 MINIMAL RESIDUAL DISEASE MRD TESTING MARKET FORECAST BY REGION

11.1 Global Minimal Residual Disease Mrd Testing Market Size Forecast
11.2 Global Minimal Residual Disease Mrd Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Minimal Residual Disease Mrd Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Minimal Residual Disease Mrd Testing Market Size Forecast by Region
  11.2.4 South America Minimal Residual Disease Mrd Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Minimal Residual Disease Mrd Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Minimal Residual Disease Mrd Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Minimal Residual Disease Mrd Testing by Type (2026-2035)
  12.1.2 Global Minimal Residual Disease Mrd Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Minimal Residual Disease Mrd Testing by Type (2026-2035)
12.2 Global Minimal Residual Disease Mrd Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Minimal Residual Disease Mrd Testing Sales (K Units) Forecast by Application
  12.2.2 Global Minimal Residual Disease Mrd Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Minimal Residual Disease Mrd Testing Market Size by Type (M USD)
Table 4. Global Minimal Residual Disease Mrd Testing Market Size by Application
Table 5. Minimal Residual Disease Mrd Testing Market Size Comparison by Region (M USD)
Table 6. Global Minimal Residual Disease Mrd Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Minimal Residual Disease Mrd Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Minimal Residual Disease Mrd Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Minimal Residual Disease Mrd Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease Mrd Testing as of 2025)
Table 11. Global Market Minimal Residual Disease Mrd Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Minimal Residual Disease Mrd Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Minimal Residual Disease Mrd Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Minimal Residual Disease Mrd Testing Sales by Type (K Units)
Table 27. Global Minimal Residual Disease Mrd Testing Market Size by Type (M USD)
Table 28. Global Minimal Residual Disease Mrd Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Minimal Residual Disease Mrd Testing Sales Market Share by Type (2020-2025)
Table 30. Global Minimal Residual Disease Mrd Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Minimal Residual Disease Mrd Testing Market Share by Type (2020-2025)
Table 32. Global Minimal Residual Disease Mrd Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Minimal Residual Disease Mrd Testing Sales (K Units) by Application
Table 34. Global Minimal Residual Disease Mrd Testing Market Size by Application
Table 35. Global Minimal Residual Disease Mrd Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Minimal Residual Disease Mrd Testing Sales Market Share by Application (2020-2025)
Table 37. Global Minimal Residual Disease Mrd Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Minimal Residual Disease Mrd Testing Market Share by Application (2020-2025)
Table 39. Global Minimal Residual Disease Mrd Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Minimal Residual Disease Mrd Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Minimal Residual Disease Mrd Testing Sales Market Share by Region (2020-2025)
Table 42. Global Minimal Residual Disease Mrd Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Minimal Residual Disease Mrd Testing Market Size by Region (2020-2025)
Table 44. North America Minimal Residual Disease Mrd Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Minimal Residual Disease Mrd Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Minimal Residual Disease Mrd Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Minimal Residual Disease Mrd Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Minimal Residual Disease Mrd Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Minimal Residual Disease Mrd Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Minimal Residual Disease Mrd Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Minimal Residual Disease Mrd Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Minimal Residual Disease Mrd Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Minimal Residual Disease Mrd Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Minimal Residual Disease Mrd Testing Production (K Units) by Region(2020-2025)
Table 55. Global Minimal Residual Disease Mrd Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Minimal Residual Disease Mrd Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Minimal Residual Disease Mrd Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Minimal Residual Disease Mrd Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Minimal Residual Disease Mrd Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Minimal Residual Disease Mrd Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Minimal Residual Disease Mrd Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Sysmex Corporation Basic Information
Table 63. Sysmex Corporation Minimal Residual Disease Mrd Testing Product Overview
Table 64. Sysmex Corporation Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Sysmex Corporation Business Overview
Table 66. Sysmex Corporation SWOT Analysis
Table 67. Sysmex Corporation Recent Developments
Table 68. Natera Basic Information
Table 69. Natera Minimal Residual Disease Mrd Testing Product Overview
Table 70. Natera Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Natera Business Overview
Table 72. Natera SWOT Analysis
Table 73. Natera Recent Developments
Table 74. Asuragen Basic Information
Table 75. Asuragen Minimal Residual Disease Mrd Testing Product Overview
Table 76. Asuragen Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Asuragen Business Overview
Table 78. Asuragen SWOT Analysis
Table 79. Asuragen Recent Developments
Table 80. Quest Diagnostics Basic Information
Table 81. Quest Diagnostics Minimal Residual Disease Mrd Testing Product Overview
Table 82. Quest Diagnostics Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Quest Diagnostics Business Overview
Table 84. Quest Diagnostics Recent Developments
Table 85. Mission Bio Basic Information
Table 86. Mission Bio Minimal Residual Disease Mrd Testing Product Overview
Table 87. Mission Bio Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Mission Bio Business Overview
Table 89. Mission Bio Recent Developments
Table 90. LabCorp Basic Information
Table 91. LabCorp Minimal Residual Disease Mrd Testing Product Overview
Table 92. LabCorp Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. LabCorp Business Overview
Table 94. LabCorp Recent Developments
Table 95. Guardant Health Basic Information
Table 96. Guardant Health Minimal Residual Disease Mrd Testing Product Overview
Table 97. Guardant Health Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Guardant Health Business Overview
Table 99. Guardant Health Recent Developments
Table 100. NeoGenomics Laboratories Basic Information
Table 101. NeoGenomics Laboratories Minimal Residual Disease Mrd Testing Product Overview
Table 102. NeoGenomics Laboratories Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NeoGenomics Laboratories Business Overview
Table 104. NeoGenomics Laboratories Recent Developments
Table 105. ARUP Laboratories Basic Information
Table 106. ARUP Laboratories Minimal Residual Disease Mrd Testing Product Overview
Table 107. ARUP Laboratories Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. ARUP Laboratories Business Overview
Table 109. ARUP Laboratories Recent Developments
Table 110. NeoGenomics , Inc Basic Information
Table 111. NeoGenomics , Inc Minimal Residual Disease Mrd Testing Product Overview
Table 112. NeoGenomics , Inc Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. NeoGenomics , Inc Business Overview
Table 114. NeoGenomics , Inc Recent Developments
Table 115. Opko Health Basic Information
Table 116. Opko Health Minimal Residual Disease Mrd Testing Product Overview
Table 117. Opko Health Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Opko Health Business Overview
Table 119. Opko Health Recent Developments
Table 120. Bio-Rad Laboratories Basic Information
Table 121. Bio-Rad Laboratories Minimal Residual Disease Mrd Testing Product Overview
Table 122. Bio-Rad Laboratories Minimal Residual Disease Mrd Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Bio-Rad Laboratories Business Overview
Table 124. Bio-Rad Laboratories Recent Developments
Table 125. Global Minimal Residual Disease Mrd Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Minimal Residual Disease Mrd Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Minimal Residual Disease Mrd Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Minimal Residual Disease Mrd Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Minimal Residual Disease Mrd Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Minimal Residual Disease Mrd Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Minimal Residual Disease Mrd Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Minimal Residual Disease Mrd Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Minimal Residual Disease Mrd Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Minimal Residual Disease Mrd Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Minimal Residual Disease Mrd Testing Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Minimal Residual Disease Mrd Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Minimal Residual Disease Mrd Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Minimal Residual Disease Mrd Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Minimal Residual Disease Mrd Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Minimal Residual Disease Mrd Testing Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Minimal Residual Disease Mrd Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Minimal Residual Disease Mrd Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Minimal Residual Disease Mrd Testing Market Size (M USD), 2025-2035
Figure 5. Global Minimal Residual Disease Mrd Testing Market Size (M USD) (2020-2035)
Figure 6. Global Minimal Residual Disease Mrd Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Minimal Residual Disease Mrd Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Minimal Residual Disease Mrd Testing Product Life Cycle
Figure 13. Minimal Residual Disease Mrd Testing Sales Share by Manufacturers in 2025
Figure 14. Global Minimal Residual Disease Mrd Testing Revenue Share by Manufacturers in 2025
Figure 15. Minimal Residual Disease Mrd Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Minimal Residual Disease Mrd Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Minimal Residual Disease Mrd Testing Revenue in 2025
Figure 18. Industry Chain Map of Minimal Residual Disease Mrd Testing
Figure 19. Global Minimal Residual Disease Mrd Testing Market PEST Analysis
Figure 20. Global Minimal Residual Disease Mrd Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Minimal Residual Disease Mrd Testing Market Share by Type
Figure 27. Sales Market Share of Minimal Residual Disease Mrd Testing by Type (2020-2025)
Figure 28. Sales Market Share of Minimal Residual Disease Mrd Testing by Type in 2025
Figure 29. Market Share of Minimal Residual Disease Mrd Testing by Type (2020-2025)
Figure 30. Market Share of Minimal Residual Disease Mrd Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Minimal Residual Disease Mrd Testing Market Share by Application
Figure 33. Global Minimal Residual Disease Mrd Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Minimal Residual Disease Mrd Testing Sales Market Share by Application in 2025
Figure 35. Global Minimal Residual Disease Mrd Testing Market Share by Application (2020-2025)
Figure 36. Global Minimal Residual Disease Mrd Testing Market Share by Application in 2025
Figure 37. Global Minimal Residual Disease Mrd Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Minimal Residual Disease Mrd Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Minimal Residual Disease Mrd Testing Market Size by Region (2020-2025)
Figure 40. North America Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Minimal Residual Disease Mrd Testing Sales Market Share by Country in 2024
Figure 43. North America Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Minimal Residual Disease Mrd Testing Market Size by Country in 2024
Figure 45. U.S. Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Minimal Residual Disease Mrd Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Minimal Residual Disease Mrd Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Minimal Residual Disease Mrd Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Minimal Residual Disease Mrd Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Minimal Residual Disease Mrd Testing Sales Market Share by Country in 2024
Figure 53. Europe Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Minimal Residual Disease Mrd Testing Market Size by Country in 2024
Figure 55. Germany Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Minimal Residual Disease Mrd Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Minimal Residual Disease Mrd Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Minimal Residual Disease Mrd Testing Market Size by Region in 2024
Figure 68. China Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Minimal Residual Disease Mrd Testing Sales and Growth Rate (K Units)
Figure 79. South America Minimal Residual Disease Mrd Testing Sales Market Share by Country in 2024
Figure 80. South America Minimal Residual Disease Mrd Testing Market Size and Growth Rate (M USD)
Figure 81. South America Minimal Residual Disease Mrd Testing Market Size by Country in 2024
Figure 82. Brazil Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Minimal Residual Disease Mrd Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Minimal Residual Disease Mrd Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Minimal Residual Disease Mrd Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Minimal Residual Disease Mrd Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Minimal Residual Disease Mrd Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Minimal Residual Disease Mrd Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Minimal Residual Disease Mrd Testing Production Market Share by Region (2020-2025)
Figure 103. North America Minimal Residual Disease Mrd Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Minimal Residual Disease Mrd Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Minimal Residual Disease Mrd Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Minimal Residual Disease Mrd Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Minimal Residual Disease Mrd Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Minimal Residual Disease Mrd Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Minimal Residual Disease Mrd Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Minimal Residual Disease Mrd Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Minimal Residual Disease Mrd Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Minimal Residual Disease Mrd Testing Market Share Forecast by Application (2026-2035)